Insider Transactions in Q1 2023 at Akebia Therapeutics, Inc. (AKBA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
David A Spellman SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
7,210
-0.7%
|
$0
$0.88 P/Share
|
|
Mar 01
2023
|
Michel Dahan SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,412
-2.4%
|
$0
$0.88 P/Share
|
|
Mar 01
2023
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,123
-0.78%
|
$0
$0.88 P/Share
|
|
Mar 01
2023
|
Nicole R. Hadas SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,034
-1.46%
|
$0
$0.88 P/Share
|
|
Mar 01
2023
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
91,868
-1.87%
|
$0
$0.88 P/Share
|
|
Feb 27
2023
|
Nicole R. Hadas SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,677
-2.17%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
David A Spellman SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
7,539
-1.44%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
Michel Dahan SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,090
-3.36%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,539
-1.22%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
38,632
-2.27%
|
$0
$0.81 P/Share
|
|
Jan 31
2023
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,200
+24.17%
|
-
|
|
Jan 31
2023
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
196,200
+27.21%
|
-
|
|
Jan 31
2023
|
John P. Butler CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
293,125
+14.71%
|
-
|